Cancer

News
Cancer-cell

App helps cancer patients manage their meds

A healthcare app due to launch at the end of this year aims to empower cancer patients and improve survival outcomes by allowing patients to better manage their medications and care.

Partner Content
immune-system-1132182_1920 (1)
Partner Content

Understanding the evolving CAR-T market

In August 2017, Novartis made history after receiving FDA approval for Kymriah, the world’s first chimeric antigen receptor T-cell (CAR-T) therapy.